| abstract |
The present invention relates to 4-methyl-8-phenoxy-1- (2-phenylethyl) -2,3-dihydro-1H-pyrrolo [3,2-c] quinoline or a pharmaceutically acceptable salt and / or solvent thereof. And an oral composition comprising chlorhexidine or a pharmaceutically acceptable salt and / or solvate thereof, wherein the composition is in the form of a mouthwash, from about 0.001% w / v. An oral composition comprising about 0.06% w / v chlorhexidine or a pharmaceutically acceptable salt and / or solvate thereof is provided. 4-methyl-8-phenoxy-1- (2-phenylethyl) -2,3-dihydro-1H-pyrrolo [3,2-c] quinoline or a pharmaceutically acceptable salt and / or solvate thereof, chlorhexidine Or an oral composition comprising a pharmaceutically acceptable salt and / or solvate thereof and a zinc compound is also provided. |